John A. Christopher

John A. Christopher

Auto-generated profile, based on publicly available information

John A. Christopher

Sosei Heptares , Steinmetz Building, Granta Park , Cambridge CB21 6DG , U.K.

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JCJohn A. Christopher
John A. Christopher
SASarah J. Aves
Sarah J. Aves
KBKirstie A. Bennett
Kirstie A. Bennett
ADAndrew S. Doré
Andrew S. Doré
JEJames C. Errey
James C. Errey
MCMiles Congreve
Miles Congreve

9 April 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
JCJohn A. Christopher
John A. Christopher
JBJason Brown
Jason Brown
ADAndrew S. Doré
Andrew S. Doré
JEJames C. Errey
James C. Errey
MKMarkus Koglin
Markus Koglin
MCMiles Congreve
Miles Congreve
Biophysical fragment screening of a thermostabilized β1-adrenergic receptor (β1AR) using surface plasmon resonance (SPR) enabled the identification of moderate affinity, high ligand efficiency (LE) arylpiperazine hits 7 and 8. Subsequent hit to lead follow-up confirmed the activity of the chemotype, and a structure-based design approach using protein–ligand crystal structures of the β1AR resulted in the identification of several fragments that bound with higher affinity, including indole 19 and quinoline 20. In the first example of GPCR crystallography with ligands derived from fragment screening, structures of the stabilized β1AR complexed with 19 and 20 were determined at resolutions of 2.8 and 2.7 Å, respectively.

18 February 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JCJohn A. Christopher
John A. Christopher
ZOZoltán Orgován
Zoltán Orgován
MCMiles Congreve
Miles Congreve
ADAndrew S. Doré
Andrew S. Doré
JEJames C. Errey
James C. Errey
György M KeserűGyörgy M Keserű
György M Keserű

20 December 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
MRMathieu Rappas
Mathieu Rappas
AAAmmar A. E. Ali
Ammar A. E. Ali
KBKirstie A. Bennett
Kirstie A. Bennett
JBJason D. Brown
Jason D. Brown
SBSarah J. Bucknell
Sarah J. Bucknell
JCJohn A. Christopher
John A. Christopher
The orexin system, which consists of the two G protein-coupled receptors OX1 and OX2, activated by the neuropeptides OX-A and OX-B, is firmly established as a key regulator of behavioural arousal, sleep and wakefulness, and has been an area of intense research effort over the past two decades. X-ray structures of the receptors in complex with ten new antagonist ligands from diverse chemotypes are presented, which complement the existing structural information for the system and highlight the critical importance of lipophilic hotspots and water molecules for these peptidergic GPCR targets. Learnings from the structural information regarding the utility of pharmacophore models and how selectivity between OX1 and OX2 can be achieved are discussed.

18 December 2013 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
SAStephen P. Andrews
Stephen P. Andrews
GBGiles A. Brown
Giles A. Brown
JCJohn A. Christopher
John A. Christopher

2 October 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RSRie Suzuki
Rie Suzuki
GBGiles A. Brown
Giles A. Brown
JCJohn A. Christopher
John A. Christopher
CSConor C. G. Scully
Conor C. G. Scully
MCMiles Congreve
Miles Congreve